tirzepatide risk of cancer Patients taking GLP-1 receptor agonists for obesity had a 41% lower obesity-related cancers as compared with patients treated with diet or exercise, a large propensity-matched cohort study showed. The results Weight-loss drugs may lower cancer

Incorporating Vitamin E-rich foods or supplements may be beneficial in supporting the treatment of IBD

Older adults, sedentary patients, or individuals who lose weight very rapidly often do better with agents that produce more moderate weight loss, an area where emerging oral options may play an important role

The increased risks associated with the compounded GLP-1 versions have resulted in an FDA advisory that, accompanied with the higher risk of potential claims, make placement of these risks difficult

It activates the MAPK/ERK signaling pathway, which tells fibroblasts (the cells that produce collagen) to ramp up production